Malaysian Journal of Analytical Sciences Vol 23 No 5 (2019): 812 - 817

DOI: 10.17576/mjas-2019-2305-06

 

 

 

APPLICATION OF DIRECT FLUORESCENCE-BASED LIVE/DEAD STAINING FOR ASSESSMENT OF ANTIFUNGAL ACTIVITY OF COCONUT OIL AGAINST Candida albicans

 

(Aplikasi Pewarnaan Hidup/Mati Berasaskan Pendarfluor Langsung untuk Penilaian Aktiviti Antikulat Minyak Kelapa terhadap Candida albicans)

 

Nor Izzah Mukhtar1, Zurainie Abllah2*, Azrul Naim Mohamad1, Intan Azura Shahdan3, Kamariah Long4, Ummi Aqilah Haron1

 

1Department of Biotechnology, Kulliyyah of Science

2Department of Pediatric Dentistry and Dental Public Health, Kulliyyah of Dentistry

 3Department of Biomedical Sciences, Kulliyyah of Allied Health Sciences

International Islamic University Malaysia, 25200 Kuantan, Pahang, Malaysia

4Biotechnology Research Centre,

MARDI Headquarters, Serdang, P.O. Box 12301, 50774 Kuala Lumpur, Malaysia

 

*Corresponding author:  drzura@iium.edu.my

 

 

Received: 16 January 2019; Accepted: 3 August 2019

 

 

Abstract

Candida albicans is one of the common causes for oral candidiasis worldwide. The proliferation of antifungal-resistant C. albicans has become a major concern. This study was carried out to evaluate activated virgin coconut oil (AVCO) and crude extract of virgin coconut oil (VCO) as new antifungal agents for treatment of oral candidiasis. C. albicans viability was determined using LIVE/DEAD bacterial viability kit. C. albicans cells were grown in yeast peptone dextrose (YPD) broth overnight. The fungus was treated with AVCO and VCO at the concentration of minimum fungicidal concentration (MFC) of 6.24 mg/mL and incubated for three different time points (1, 2, and 3 h). To evaluate the viability of C. albicans, SYTO 9 and propidium iodide (PI) staining were used and the cells were observed using fluorescence microscopy. C. albicans treated with AVCO showed more dead cells compared to cells treated with VCO. The data indicate that exposure of C. albicans to AVCO was the most inhibitory to its growth (p < 0.01).

 

Keywords:  LIVE/DEAD staining, `antifungal activity, Candida albicans, virgin coconut oil

 

Abstrak

Candida albicans ialah salah satu penyebab kepada kandidiasis mulut di seluruh dunia. Malahan, pembiakan C. albicans rintang antikulat semakin mendapat perhatian. Kajian ini dijalankan untuk menilai kesan-kesan minyak kelapa dara teraktif (AVCO) dan ekstrak minyak kelapa dara (VCO) dalam pencarian agen antikulat yang baharu untuk rawatan kandidiasis mulut. Kebolehhidupan sel C. albicans ditentukan dengan penggunaan kit daya kebolehhidupan bakteria HIDUP/MATI. C. albicans dibiakkan semalaman di dalam kultur cecair yis pepton dekstrosa (YDP). Kulat tersebut dirawat dengan minyak kelapa teraktif dan ekstrak minyak kelapa dara pada kepekatan fungisidal minimum (MFC) sebanyak 6.24 mg/mL dan dieramkan pada tiga masa yang berbeza (1, 2, dan 3 jam). Untuk menilai kebolehhidupan C. albicans, pewarnaan SYTO 9 dan propidium iodida digunakan dan sel dilihat dengan menggunakan mikroskop pendarfluor. C. albicans yang telah dirawat dengan minyak kelapa dara teraktif menunjukkan lebih banyak sel yang mati berbanding sel yang dirawat dengan ekstrak minyak kelapa dara. Data menunjukkan minyak kelapa dara teraktif adalah paling berkesan untuk menghalang pembiakan C. albicans (p < 0.01).

 

Kata kunci:  pewarnaan HIDUP/MATI, aktiviti rintang kulat, C. albicans, minyak kelapa dara

 

References

1.       Chanda, W., Joseph, T. P., Wang, W., Padhiar, A. A. and Zhong, M. (2017). The potential management of oral candidiasis using anti-biofilm therapies. Medical Hypotheses, 106: 15 - 18.

2.       Gow, N. A., and Hube, B. (2012). Importance of the Candida albicans cell wall during commensalism and infection. Current Opinion in Microbiology, 15 (4): 406 - 412.

3.       Katiraee, F., Khalaj, V., Khosravi, A., and Hajiabdolbaghi, M. (2014). Sequences type analysis of candida albicans isolates from iranian human immunodeficiency virus infected patients with oral candidiasis. Acta Medica Iranica, 52(3): 187 - 191.

4.       Millsop, J.W. and Fazel, N. (2016). Oral candidiasis. Clinics in Dermatology, 34(4): 487 - 494.

5.       Perlroth, J., Choi, B. and Spellberg, B. (2007). Nosocomial fungal infections: Epidemiology, diagnosis, and treatment. Medical Mycology, 45(4): 321 – 346.

6.       Silva, S., Henriques, M., Hayes, A., Oliveira, R., Azeredo, J., and Williams, D. W. (2011). Candida glabrata and Candida albicans coinfection of an in vitro oral epithelium. Journal of Oral Pathology & Medicine, 40(5): 421 - 427.

7.       Vasconceles, L. C., Sampaio, F. C., dos Reis Albuquerque, A. J. and Souza Vasconcelos, L. C. (2014). Cell viability of candida albicans against the antifungal activity of thymol. Brazilian Dental Journal, 25 (4): 227 - 281.

8.       Kong, E. F., Kucarikova, S., Dijck, P. V., Peters, B.M., Shirtliff, M. E. and Jabra-Rizk, M. A. (2015). Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease. Infection and Immunity, 83(2): 604 - 613.

9.       Pfaller, M. A. and Diakema, D. J. (2007). Epidemiology of invasive candidiasis: A persistent public health problem. Clinical Microbiology Reviews, 20(1): 133 - 163.

10.    Fidel, P. L. (2011). Candida-host interactions in HIV disease: Implications for oropharyngeal candidiasis. Advances in Dental Research, 23(1): 45 - 49.

11.    Lyu, X., Zhao, C., Yan, Z., and Hua, H. (2016). Efficacy of nystatin for the treatment of oral candidiasis: A systematic review and meta-analysis. Drug Design, Development and Therapy, 10: 1161 - 1171.

12.    Dhanasekaran, D., Vinothini, K., Latha, S., Thajuddin, N. and Paneerselyam, A. (2014). Human dental biofilm: screening, characterization, in vitro biofilm formation and antifungal resistance of Candida spp. The Saudi Journal for Dental Research, 5(1): 55 - 70.

13.    Mosci, P., Gabrielli, E., Luciano, E., Perito, S., Cassone, A., Pericolini, E., and Vecchiarelli, A. (2014). Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection. Microbes and Infection, 16(8): 678 - 689.

14.    He, M., Du, M., Fan, M. and Bian, Z. (2007). In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia, 163: 137 - 143.

15.    Ilyas, M. and Sharma, A. (2017). Cutaneous fungal infections in solid organ transplant recipients. Transplantation Reviews, 31(3): 158 - 165.

16.    Jin, Y., Zhang, T., Samaranayake, Y. H., Fang, H. H. P., Yip, H. K., and Samaranayake, L. P. (2005). The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia, 159(3): 353 - 360.

17.    Rasteiro, V. M. C., Costa, A. C. B. P., Araujo, C. F., Barros, P. P., Rossoni, R. D., Anbinder, A. L., Jorge, A. O. C. and Junquiera, J. C. (2014). Essential oil of Melaleuca alternifolia for the treatment of oral candidiasis induced in an immunosuppressed mouse model. BMC Complementary and Alternative Medicine, 14: 489 - 499.

18.    Schelenz, S., Abdallah, S., Gray, G., Stubbings, H., Gow, I., Baker, P. and Hunter P. R. (2011). Epidemiology of oral yeast colonization and infection in patients with haematological malignancies, head neck and solid tumors. Journal of Oral Pathology Medicine, 40: 83 - 89.

19.    Thompson III, G. R., Patel, P. K., Kirkpatrick, W. R., Westbrook, S. D., Berg, D., Erlandsen, J., Redding, S. W. and Patterson, T. F. (2010). Oropharyngeal Candidiasis in the Era of Antiretroviral Therapy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 109 (4): 488 - 495.

20.    Williams D. W., Kuriyama T., Silva, S., Malic, S. and Lewis, M. A. O. (2011). Candida biofilms and Oral candidosis: Treatment and prevention. Periodontology 2000, 55: 250-265.

21.    Lima, E. B. C., Sousa, C. N. S., Meneses, L. N., Ximenes, N. C., Júnior, S., Vasconcelos, G. S., Lima, N. B., Patocinio, M. C., Macedo., D. and Vasconcelos, S. M. M. (2015). Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review. Brazilian Journal of Medical and Biological Research, 48(11): 953 - 964.

22.    Long K. Modified coconut oils with broad antimicrobial spectrum. Malaysian Granted Patent MY140578-A. 2009. https://patents.google.com/patent/WO2007067028A1. [Access online 26 November 2017].

23.    Soo-Peng, K., Harun, D., Mat-Amin, M. and Long, K. (2016). Enhanced virgin coconut oil (EVCO) as natural postmilking teat germicide to control environmental mastitis pathogens. International Journal of Biotechnology for Wellness Industries, 5: 128 - 134.

24.    Haron, U. A., Abllah, Z. and Nasir, N. A. M. M. (2018). The comparative antimicrobial effect of activated virgin coconut oil (AVCO) and virgin coconut oil (VCO) against dental caries-related pathogens. Advances in Health Science Research, 8: 312 - 317.

 




Previous                    Content                    Next